A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating Women

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 9, 2025

Primary Completion Date

July 22, 2026

Study Completion Date

July 22, 2026

Conditions

Healthy Participants

Interventions

DRUG

Zilucoplan

Dose formulation: Solution for injection. Route of administration: Subcutaneous injection.

Trial Locations (2)

RECRUITING

UP0137 2, San Antonio

RECRUITING

UP0137 1, Salt Lake City

All Listed Sponsors

lead

UCB Biopharma SRL

INDUSTRY

NCT06961747 - A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating Women | Biotech Hunter | Biotech Hunter